These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 29855203)
21. Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review. Yin J; Xia X; Shi Y; Lu Y; Zhao C; Huang Z; Tian N Amyloid; 2014 Jun; 21(2):140-2. PubMed ID: 24601824 [No Abstract] [Full Text] [Related]
24. A case of transthyretin-related cerebral amyloid angiopathy. The other side of hereditary transthyretin amyloidosis. Lemarchant B; Lebouvier T; Delbeuck X; Gibier JB; Tard C Acta Neurol Belg; 2022 Apr; 122(2):571-573. PubMed ID: 35040071 [TBL] [Abstract][Full Text] [Related]
25. Hereditary amyloid neuropathy by transthyretin Val107 mutation in a patient of African origin. Cassereau J; Lavigne C; Letournel F; Ghali A; Verny C; Dubas F; Devière F; Nicolas G J Peripher Nerv Syst; 2008 Sep; 13(3):251-4. PubMed ID: 18844793 [No Abstract] [Full Text] [Related]
26. Transthyretin-related hereditary amyloidosis in an Argentinian family with TTR Tyr114Cys mutation. Aguirre MA; Nucifora EM; Rugiero M; Sorroche P; Saez MS; Giunta DH; Posadas-Martinez ML; Boietti BR Amyloid; 2017 Mar; 24(sup1):102. PubMed ID: 28434328 [No Abstract] [Full Text] [Related]
27. The current status of the Transthyretin Amyloidosis Outcomes Survey (THAOS) in Japan. Sekijima Y; Mundayat R; Ishii T; Ando Y Amyloid; 2019; 26(sup1):61-62. PubMed ID: 31343365 [No Abstract] [Full Text] [Related]
28. The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study. Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sakurai T; Shimohata T; Katsuno M; Sobue G J Neurol Sci; 2018 Nov; 394():99-106. PubMed ID: 30243104 [TBL] [Abstract][Full Text] [Related]
29. Teaching NeuroImages: Neuromyopathy in a patient with hereditary transthyretin Thr60Ala amyloidosis. Pinto MV; Tracy JA; Grogan M; Mauermann ML Neurology; 2019 Mar; 92(12):e1403-e1404. PubMed ID: 30886082 [No Abstract] [Full Text] [Related]
30. Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis. Lau KHV; Prokaeva T; Zheng L; Doros G; Kaku MC; Spencer B; Berk J; Sanchorawala V Amyloid; 2024 Jun; 31(2):150-152. PubMed ID: 38073425 [No Abstract] [Full Text] [Related]
31. Transthyretin Cardiac Amyloidosis Due to Homozygous Val122Ile Mutation in a Caucasian Man. Marrero Negrín N; Medina Gil JM; García Cruz ML; Jiménez Cabrera F Rev Esp Cardiol (Engl Ed); 2019 Dec; 72(12):1086-1088. PubMed ID: 31561982 [No Abstract] [Full Text] [Related]
32. Case report of a young patient with transthyretin amyloidosis associated with Gly67Ala mutation. Salihoglu A; Yildirim S; Ar MC; Hancer VS; Bozcan S; Yilmaz U; Serin N; Tuzuner N; Celik AF Amyloid; 2019; 26(sup1):75-76. PubMed ID: 31343303 [No Abstract] [Full Text] [Related]
33. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367 [TBL] [Abstract][Full Text] [Related]
34. A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation. Matsumoto S; Ueda M; Yamashita T; Amano T; Misumi Y; Tasaki M; Masuda T; Mizukami M; Furuya H; Ando Y Amyloid; 2017 Mar; 24(sup1):97-98. PubMed ID: 28434367 [No Abstract] [Full Text] [Related]
35. Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis. Wixner J; Pilebro B; Lundgren HE; Olsson M; Anan I Amyloid; 2017 Mar; 24(sup1):78-79. PubMed ID: 28042702 [No Abstract] [Full Text] [Related]
36. Electrochemical skin conductance in hereditary amyloidosis related to transthyretin V30M - a promising tool to assess treatment efficacy? Castro J; Costa J; de Castro I; Conceição I Amyloid; 2018 Dec; 25(4):267-268. PubMed ID: 30773060 [No Abstract] [Full Text] [Related]
37. Changes in nerve excitability indices in hereditary transthyretin amyloidosis. Yamashita T; Ueda M; Misawa S; Inoue Y; Masuda T; Misumi Y; Takamatsu K; Obayashi K; Kuwabara S; Ando Y Amyloid; 2019; 26(sup1):9-10. PubMed ID: 31343340 [No Abstract] [Full Text] [Related]
38. Myopathic phenotype of familial amyloid polyneuropathy with a rare transthyretin variant: ATTR Ala45Asp. Misumi Y; Doki T; Ueda M; Obayashi K; Tasaki M; Tamura A; Ando Y Amyloid; 2014 Sep; 21(3):216-7. PubMed ID: 24953234 [No Abstract] [Full Text] [Related]
39. Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy. Li H; Zhang Y; Cao L; Xiong R; Zhang B; Wu L; Zhao Z; Chen SD Drug Des Devel Ther; 2014; 8():2121-8. PubMed ID: 25382970 [TBL] [Abstract][Full Text] [Related]